Literature DB >> 7510596

The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis.

J Chiba1, H E Rubash, K J Kim, Y Iwaki.   

Abstract

The histologic, biochemical, and immunohistologic characteristics of the interface membranes surrounding the femoral component of failed cementless total hip arthroplasty (THA) in patients with (Group I) and without (Group II) radiographic evidence of focal endosteal erosion (osteolysis) were studied. Group I membranes had more macrophages and small particles of polyethylene debris in the membrane, but both groups had similar amounts of metal particles. A greater activity level of interleukin-1 (IL-1), tumor necrosis factor (TNF), and interleukin-6 (IL-6) was seen in the culture supernatant of the membranes from Group I than in that of Group II. Group I membranes also had more cells (macrophages, fibroblasts, and endothelial cells) that stained positively with anti-IL-6 antibody. These results suggest that IL-6, IL-1, and TNF play a role in the focal femoral osteolysis observed in patients with failed cementless hip prostheses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510596

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  24 in total

1.  The effect of particle size and electrical charge on macrophage-osteoclast differentiation and bone resorption.

Authors:  A Sabokbar; R Pandey; N A Athanasou
Journal:  J Mater Sci Mater Med       Date:  2003-09       Impact factor: 3.896

2.  Early aseptic loosening of cemented total hip arthroplasty: the influence of non-steroidal anti-inflammatory drugs and smoking.

Authors:  M H A Malik; J Gray; P R Kay
Journal:  Int Orthop       Date:  2004-03-27       Impact factor: 3.075

3.  Periprosthetic osteolysis: characterizing the innate immune response to titanium wear-particles.

Authors:  Christine A St Pierre; Melvin Chan; Yoichiro Iwakura; David C Ayers; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Orthop Res       Date:  2010-11       Impact factor: 3.494

Review 4.  The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses.

Authors:  Peter A Revell
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

5.  Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR).

Authors:  J W Xu; Y T Konttinen; V Waris; H Pätiälä; T Sorsa; S Santavirta
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

Review 6.  Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement.

Authors:  Jiri Gallo; Jana Vaculova; Stuart B Goodman; Yrjö T Konttinen; Jacob P Thyssen
Journal:  Acta Biomater       Date:  2014-02-10       Impact factor: 8.947

7.  Innate immune reactions in septic and aseptic osteolysis around hip implants.

Authors:  Jukka Pajarinen; Eemeli Jamsen; Yrjo T Konttinen; Stuart B Goodman
Journal:  J Long Term Eff Med Implants       Date:  2014

8.  In vivo imaging of particle-induced inflammation and osteolysis in the calvariae of NFκB/luciferase transgenic mice.

Authors:  Kunihiko Takahashi; Shin Onodera; Harukazu Tohyama; Hyuck Joon Kwon; Ken-ichi Honma; Kazunori Yasuda
Journal:  J Biomed Biotechnol       Date:  2010-09-21

9.  Human monocyte-derived macrophages and dendritic cells as targets for biomaterial cytocompatibility studies using an improved in vitro culture system.

Authors:  E Mebouta-Nkamgueu; J J Adnet; D Ittelet; D Laurent-Maquin; S Bouthors; G Potron; M Guenounou; J Bernard
Journal:  J Mater Sci Mater Med       Date:  2001-04       Impact factor: 3.896

10.  Effect of particles and interface conditions on fibrous tissue interposition between bone and implant. A particle challenge model in rabbit.

Authors:  H Ohashi; A Kobayashi; Y Kadoya; Y Yamano; H Oonishi; H Iwaki
Journal:  J Mater Sci Mater Med       Date:  2000-04       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.